QLS12010

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QLS12010, covering 2026-02-02 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa [Phase 2]